Invention Grant
- Patent Title: Antiviral heterocyclic compounds
-
Application No.: US17679746Application Date: 2022-02-24
-
Publication No.: US11945830B2Publication Date: 2024-04-02
- Inventor: Adam Szymaniak , Jianming Yu , Kevin McGrath , Xiben Li , Tyler J. Mann , Robert Leon , In Jong Kim , Yat Sun Or , Long Nguyen
- Applicant: Enanta Pharmaceuticals, Inc.
- Applicant Address: US MA Watertown
- Assignee: Enanta Pharmaceuticals, Inc.
- Current Assignee: Enanta Pharmaceuticals, Inc.
- Current Assignee Address: US MA Watertown
- Agency: Elmore Patent Law Group
- Agent Edgar W. Harlan; Carolyn S. Elmore
- Main IPC: C07F9/09
- IPC: C07F9/09 ; A61K31/14 ; A61K31/4355 ; A61K31/4365 ; A61K31/437 ; A61K31/444 ; A61K31/4709 ; A61K31/497 ; A61K31/501 ; A61K31/502 ; A61K31/519 ; A61K45/06 ; C07D491/048 ; C07D519/00
Abstract:
The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof:
which inhibit Human Respiratory Syncytial Virus (HRSV) or Human Metapneumovirus (HMPV) inhibitors. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HRSV or HMPV infection. The invention also relates to methods of treating an HRSV or HMPV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.
which inhibit Human Respiratory Syncytial Virus (HRSV) or Human Metapneumovirus (HMPV) inhibitors. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HRSV or HMPV infection. The invention also relates to methods of treating an HRSV or HMPV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.
Information query
